INTRODUCTIONReoperative parathyroidectomy is required when there is persistent or recurrent hyperparathyroidism following the initial surgery (at least 5% of parathyroidectomies nationally). By convention, 'persistent disease' is defined as the situation where the patient has not been cured by the first operation. The term 'recurrent hyperparathyroidism' is used when the patient was confirmed to be biochemically cured for six months from the first operation but has hyperparathyroidism after this date. Reoperative surgery is associated with higher rates of postoperative complications as well as a greater rate of failure to cure. The aim of our study was to review our departmental experience of reoperative parathyroidectomy, with a view to identify patterns of disease persistence and recurrence. METHODS Using a departmental database, patients were identified who had undergone reoperative parathyroidectomy between 2006 and 2014. All the pre, intra and postoperative information was documented including the operative note so as to record the location of the abnormal parathyroid gland found at reoperation. RESULTS Almost two-thirds (63%) of patients had negative, equivocal or discordant conventional imaging so secondary investigative tools were required frequently. The majority of abnormal glands were found in eutopic locations. The most common locations for ectopic glands were intrathyroidal, mediastinal and intrathymic. A third (33%) of the patients had multigland disease and over a quarter (28%) had coexisting thyroid disease. CONCLUSIONS Persistent hyperparathyroidism represents a challenging patient subgroup for which access to all radiological modalities and intraoperative parathyroid hormone monitoring are required. Patient selection for reintervention is a key determinant in the reoperation cure rate. Primary hyperparathyroidism (HPT) is caused by a single adenoma in approximately 90%, multigland disease including adenomas or hyperplasia in 10% and parathyroid carcinoma in under 1% of cases.1 Parathyroidectomy remains the definitive cure of primary HPT and the procedure of choice in refractory tertiary HPT in renal failure patients both before and after renal transplantation. Failure to cure HPT at the first operation (persistent HPT) is reported to occur in 5% of cases, both in the literature and in national registry data, but this is very probably underreported.2,3 In contrast, patients with recurrent HPT will have been biochemically cured (normal serum calcium and accommodated parathyroid hormone) for more than six months since the initial operation.Patients who have ongoing HPT despite a previous operation are candidates for a reoperative parathyroidectomy. This surgery is associated with higher rates of postoperative complications as well as a lower chance of being cured. 4,5 The aim of our study was to review our departmental experience of reoperative parathyroidectomy with a view to identifying patterns of disease persistence and recurrence.